| Assessment Status | Rapid Review Complete |
| HTA ID | 23031 |
| Drug | Itopride Hydrochloride |
| Brand | Progit® |
| Indication | Treatment of gastrointestinal symptoms of functional dyspepsia caused by reduced gastrointestinal motility. |
| Assessment Process | |
| Rapid review commissioned | 06/06/2023 |
| Rapid review completed | 07/07/2023 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that itopride not be considered for reimbursement at the submitted price*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.